Product Information
OSELTAMIVIR PHOS 75 MG CAPSULE is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.7962 per EA under NDC 70710101002. Its NADAC has been published 495 times since Apr 12, 2017.
FDA first approved this application on Feb 24, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710101002
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA208578FDA Approved
2/24/2017
TE Code
AB
On Market Since
2/24/2017
Pharmacological Classes
Price Statistics
The NADAC for OSELTAMIVIR PHOS 75 MG CAPSULE has been published 495 times since Apr 12, 2017, and over the history we have for it it has declined 91.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7962 per EA |
|---|---|
| All-time high | $9.0260 (May 10, 2017) |
| All-time low | $0.7575 (Nov 20, 2024) |
| 52-week high | $0.9163 |
| 52-week low | $0.7962 |
| Median price | $1.4725 |
| Average price | $2.9181 |
| Largest weekly change | -37.2% (Sep 22, 2021) |
| Weeks tracked | 495 |
| Tracking since | Apr 12, 2017 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
oseltamivir phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Neuraminidase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OSELTAMIVIR PHOS 75 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR PHOS 75 MG CAPSULE, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.7962 per EA (NDC 70710101002), effective Sep 30, 2026.
How has the price of OSELTAMIVIR PHOS 75 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OSELTAMIVIR PHOS 75 MG CAPSULE has declined 91.2%. It has been tracked across 495 weekly CMS publications since Apr 12, 2017.
What are the highest and lowest recorded NADAC prices for OSELTAMIVIR PHOS 75 MG CAPSULE?
Since Apr 12, 2017, the NADAC for OSELTAMIVIR PHOS 75 MG CAPSULE has ranged from a low of $0.7575 (Nov 20, 2024) to a high of $9.0260 (May 10, 2017), with a median of $1.4725 per EA.
Are there cheaper alternatives to OSELTAMIVIR PHOS 75 MG CAPSULE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OSELTAMIVIR PHOS 75 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures OSELTAMIVIR PHOS 75 MG CAPSULE?
OSELTAMIVIR PHOS 75 MG CAPSULE (NDC 70710101002) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.